Wageningen University Appoints New Professor to Predict Animal Virus Outbreaks

2026-09-08 bio

Wageningen, Tuesday, 8 September 2026.
Appointed on September 1, 2026, Barry Rockx will lead research using advanced 3D laboratory models of blood vessels and placentas to predict and prevent future animal virus outbreaks.

A Crucial Convergence of Agritech and Medicine

This pioneering research sits directly at the intersection of agritech, healthtech, and medicine, driven by the “One Health” framework [1][2][7]. By studying how emerging viruses in livestock and wildlife cause disease and spread, the initiative directly supports the agricultural sector (agritech) by securing livestock supply chains and preventing devastating economic losses [1][2]. Concurrently, because many of these pathogens possess zoonotic potential—meaning they can cross the species barrier from animals to humans—the research serves as a vital medical and public health safeguard [2][7]. The ultimate goal is to transition from a reactive model of outbreak management to a proactive, predictive system that protects both animal welfare and human global health [2][7].

The Institutions and Leadership Behind the Innovation

The scientist responsible for leading this initiative is Barry Rockx, who was appointed to a special chair in the Pathogenesis of Emerging Veterinary Viruses on September 1, 2026 [2][6]. This academic role is based at the Laboratory of Virology, which is part of the Plant Sciences Group at Wageningen University & Research (WUR) in Wageningen, Netherlands [1][2][3]. To maximize the impact of his research, Rockx’s appointment serves to bridge the fundamental virology research conducted at WUR’s Laboratory of Virology with the applied veterinary research, diagnostics, and disease expertise at Wageningen Bioveterinary Research (WBVR) [2][7], where Rockx has also served as a senior scientist and project leader since 2022 [2][6].

How the 3D Laboratory Modeling Works

The core methodology of this research relies on advanced, non-animal laboratory models [7]. Rockx and his research group develop three-dimensional (3D) laboratory models of complex biological structures, such as host blood vessels and the placental barrier [1][2][7]. By recreating these physiologically relevant structures in vitro, the team can accurately simulate host-pathogen interactions and analyze how viruses behave inside animal and human hosts without relying on live subjects [2][7]. This allows scientists to closely observe how viruses cross cellular barriers and identify the exact mechanisms they use to cause illness [2][7].

Predicting Transmission and Vector-Borne Threats

The cellular data generated from these 3D models is subsequently integrated into sophisticated transmission models and risk assessments [2][7]. This integration helps researchers understand not just how a virus behaves inside an individual host, but how it might spread across an entire population [7]. A primary focus of the chair is on vector-borne viruses—those transmitted by vectors such as mosquitoes, biting midges, and ticks [1][2][7]. These include the Rift Valley fever virus, bluetongue virus, West Nile virus, and tick-borne encephalitis virus [2][6][7]. Developing these early-warning systems is highly critical given recent environmental pressures, highlighted by the rise of West Nile virus infections in horses and the introduction of the Shamonda virus in cattle [1][2][5].

A Decade of High-Containment Expertise

Rockx brings a deep background in high-consequence pathogen research to this role [2]. He earned his PhD from Utrecht University in Utrecht, Netherlands, in 2004, where he specialized in norovirus susceptibility and antibody responses [2][5]. Following his doctorate, Rockx spent nearly ten years in the United States working at prestigious institutions including the University of North Carolina, the Rocky Mountain Laboratories of the US National Institutes of Health, and the University of Texas Medical Branch [2]. During this time, he investigated highly dangerous pathogens such as SARS-CoV, influenza, henipaviruses, and filoviruses under maximum-containment Biosafety Level 4 (BSL-4) conditions [2][5]. This academic appointment in 2026 comes exactly 22 years after he completed his PhD, representing over two decades of specialized virology expertise [2][5].

Securing the Future Against Zoonotic Spillover

After returning to the Netherlands in 2014, Rockx directed surveillance and diagnostics for rare and emerging viral infections at the National Institute for Public Health and the Environment (RIVM) in Bilthoven [alert! ‘exact location of RIVM not explicitly in source, though RIVM is Dutch national institute’] and led the Exotic Viruses workgroup at Erasmus MC in Rotterdam [2][5]. By combining this extensive background in public health, diagnostics, and fundamental research, the new chair aims to create a future where emerging veterinary outbreaks no longer take society by surprise [2][7]. The strategic integration of fundamental and applied science will allow policy makers, biosecurity experts, and agricultural managers to take targeted, timely action before localized viral spillovers escalate into major national or global crises [2][7].

Bronnen

animal virology outbreak prevention